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Expanding the scope of NS acyl transfer in native peptide 
sequences  
Ben Cowper, Leila Shariff, Wenjie Chen, Samantha M. Gibson, Wei-Li Di and Derek Macmillan* 
Understanding the factors that influence NS acyl transfer in native peptide sequences, and discovery of new reagents 
that facilitate it, will be key to expanding its scope and applicability.  Here, through a study of short model peptides in 
thioester formation and cyclisation reactions, we demonstrate that a wider variety of Xaa-Cys motifs than originally 
envisaged are capable of undergoing efficient NS acyl transfer.  We present data for the relative rates of thioester 
formation and cyclisation for a representative set of amino acids, and show how this expanded scope can be applied to the 
production of the natural protease inhibitor Sunflower Trypsin Inhibitor-1 (SFTI-1). 
Introduction 
Native chemical ligation (NCL, Scheme 1) has emerged as the 
reaction of choice when it comes to the chemical synthesis of 
proteins.1-3  It offers atomic level control of protein sequence 
and structure and is amenable to the production of both natural4-
7 and unnatural8, 9 protein products.  The thioester component of 
the NCL reaction is so central to its success that a multitude of 
methods have emerged for its production by using either 
Fmoc10-19 or Boc-based20-24 solid-phase peptide chemistry 
approaches.  Each method has desirable attributes and, usually, 
some limitations.  This is evidenced by the fact that no single 
method for thioester synthesis has been universally adopted, 
although certain methods are more routinely used than others 
for their reliability in producing long peptide thioesters.  
  
 
 
 
 
 
 
Scheme 1: The process of Native Chemical Ligation (NCL).  The peptide 
thioester (R= alkyl, or aryl), whether pre-assembled or produced in-situ, is 
central to its success. 
 
One area of thioester synthesis that has received much recent 
attention is the post-synthesis production of thioesters by NS 
acyl transfer,13, 25-29 owing to its similarity to the intriguing 
process of protein splicing mediated by inteins, which forms the 
basis of NCL’s biological counterpart, expressed protein 
ligation (EPL).30-34  An early observation of the generally poor 
susceptibility of native peptides to undergo NS acyl transfer 
at room temperature or below26 perhaps prompted examination 
of several synthetic “devices”, which generally invoke the use 
of tertiary amides of β-amino thiol (cysteine-like) derivatives, 
to facilitate the process (Scheme 2).29, 35-48  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Scheme 2: Thioester formation via cysteine mediated reverse NCL  and 
some alternative building blocks that also enable NS acyl transfer and 
thioester formation in peptides. 
In our laboratory we explored thioester synthesis via NS acyl 
transfer in native peptide sequences terminating in a C-terminal 
cysteine residue.49  While many of the thioester precursors 
shown in scheme 2 are reported to facilitate thioester 
production under milder conditions than when using cysteine 
alone, the majority of these devices have optimal reactivity 
under similar reaction conditions (35-40oC, pH<7 rather than 
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45-55oC, pH<7).38, 39  In our early experiments,49, 50 reactions 
were often conducted in aqueous 3-mercaptopropionic acid or 
10% acetic acid, with thioester precursors prepared as C-
terminal carboxamides (Xaa-Cys-NH2), which we now know to 
be significantly less reactive than the corresponding C-terminal 
carboxylates (Xaa-Cys-OH).51  The combination of 
carboxamide-terminated precursor and acidic solvents led us to 
the conclusion that the reaction was likely only to be practically 
useful across Gly-Cys, His-Cys, and Cys-Cys motifs.52  
 
In fact NS acyl transfer in native peptides bearing a C-
terminal Gly-Cys carboxylate (Gly-Cys-OH) motif occurs to an 
observable extent at room temperature, this process is currently 
impractical in light of at least two further influencing factors.  
The first is that the thioester product has limited stability under 
the reaction conditions and so thioester formation does not 
profit from a protracted reaction time.  The second is that a 
mildly reducing environment must be maintained throughout 
the process and this is more difficult to achieve in a user 
friendly manner over a longer duration.  Furthermore the 
addition of chemical reducing agents is not without 
complication.53  Consequently thioester formation is often 
conducted at 60oC when this temperature is well tolerated, but 
we have also reported several successful reactions at 
temperatures ranging from 45-50oC.54-57  Additionally, we have 
demonstrated that peptide hydrazides, which can be formed as 
“shelf-stable” thioester equivalents can also be formed at lower 
temperature and are more stable to prolonged reaction times 
than the corresponding thioester.57  
 
An advantage of using a single native amino acid residue to 
facilitate thioester synthesis is its operational simplicity, 
requiring only standard procedures, and readily available resins 
and amino acids.  Synthesis monitoring is trivial and standard 
resin cleavage procedures furnish the desired thioester 
precursor.  A further advantage is that, because the NS acyl 
transfer “apparatus” (i.e. a C-terminal Cys residue) is a simple 
amino acid, the entire peptide precursor can be produced 
biologically.  This potentially addresses a major issue 
associated with peptide therapeutics, the inefficiency and cost 
of their synthesis. A potential disadvantage of the process is 
that it may be limited to particularly reactive peptide sequences, 
which may necessitate introduction of an amino acid 
substitution in order to facilitate the chemistry.  However, here 
we show how thioesters can form readily in short peptide 
sequences terminating in a representative selection of Xaa-Cys-
OH motifs.  Analysis of the reaction mixtures showed that, in 
fact, peptides terminating in a greater variety of Xaa-Cys-OH 
motifs undergo thioester formation and cyclisation at rates 
similar to motifs that were previously considered to be 
especially privileged.  
Results and Discussion 
Factors influencing thioester formation and cyclisation  
At first glance one might expect all Xaa-Cys sites within a 
target peptide or protein to be similarly susceptible to NS 
acyl transfer.  However, this is not the case and selectivity and 
efficiency originate from a number of sources.  We have shown 
previously that β-branched amino acids, present as Xaa-Cys-
NH2 or internal Xaa-Cys motifs, are essentially inert to NS 
acyl transfer under the reaction conditions.  This imparts 
considerable inherent selectivity at the sequence level.55  The 
fact that thiolysis of terminal Xaa-Cys-OH motifs occurs 
significantly more rapidly than across the corresponding 
internal Xaa-Cys and Xaa-Cys-NH2 motifs affords another 
level of selectivity,57 which persists whether the C-terminal 
residue is L-cysteine, D-cysteine or selenocysteine,56 and 
appears independent of the peptide sequence (Figures 1a/b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. NS acyl transfer reaction progress, followed by 13C NMR spectroscopy,26,50 highlights similarities and differences in reactivity between various thioester precursor 
peptides. a) Thioester formation (sequence H-NPMGYTKEGC-OH) is more rapid when the peptide C-terminus possesses a free carboxyl group 2a/3a regardless of whether the C-
terminal residue is D- or L-configured. b) In precursor H-MEELYKSGC-OH this trend is retained and lower reactivity is also observed with methyl ester 4. c) Reconstituting the C-
terminal carboxyl group through a single amino acid spacer does not restore reactivity.  All reactions were conducted at 60oC. 
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Interestingly the methyl ester terminated precursor (Xaa-Cys-
OMe) also forms a thioester at approximately the same rate as 
its carboxamide terminated counterpart (Figure 1b).   
 
One explanation for the rate enhancement attributable to the 
carboxyl group is that the S-peptide intermediate formed upon 
NS acyl shift is zwitterionic.  It is widely appreciated that the 
zwitterionic form of an amino acid is the most stable in aqueous 
solution and the electrostatic stability of a zwitterion provides a 
barrier to peptide bond formation (SN acyl shift).  
Consequently the liberated NH3
+ group of cysteine is likely to 
be more basic than the corresponding NH3
+ group from 
cysteineamide and perhaps unsurprisingly the enhanced 
reactivity of Xaa-Cys-OH motif is not transmitted through an 
extended zwitterionic dipeptide leaving group (Figure 1c).  In 
general, if the reaction pH is not adjusted after all of the 
components (peptide, buffer, MESNa, and TCEP) are mixed, 
the final pH is between pH 3 and pH 5. However, by lowering 
the pH of the reaction we might expect that increased 
protonation of the carboxyl group would reduce any stabilising 
effect of the zwitterionic form giving rise to less thioester, 
whereas an Xaa-Cys-NH2 motif may be positively influenced 
by the lower pH, favouring S-peptide formation.  While the rate 
of thioester production across Xaa-Cys-OH motifs does appear 
to be reduced as the pH is lowered (Figure 2), thioester 
formation is not dramatically affected by changes in pH from 
pH 2-pH 5, possibly because the cysteine carboxyl group (pKa 
~2.0) is still significantly ionised at pH 2. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Thioester formation from precursor sequences H-NPMGYTKEGC-OH (red) and 
H-NPMGYTKEGC-NH2 (blue) after 24 h as a function of pH was determined by 
13C NMR 
spectroscopy.  The red line corresponds to [% thioester + % hydrolysis] since H-
NPMGYTKEG-OH presumably arises from hydrolysis of H-NPMGYTKEG-SR.  Hydrolysis 
was not observed in the Xaa-Cys-NH2 reactions since the quantity of thioester is small 
(see supporting information for all data).   
 
When NS acyl shift precedes cyclisation, when the thioester 
precursor also possesses an N-terminal cysteine residue, the 
thioester may only be generated fleetingly.54, 55, 58  Intercepting 
the thioester with an N-terminal cysteine residue appears to 
form a cyclic product essentially irreversibly as a result of 
forming the less reactive internal Xaa-Cys motif.  Whether or 
not the thioester intermediate is observed at all in Cys/Gly/His-
Cys-OH terminated peptides depends primarily on the reaction 
pH and the size of the peptide macrocycle. 
For small peptide macrocycles (up to ~15 residues) this allows 
us to use an expanded set of thiol additives such as 3-
mercaptopropanol.  3-mercaptopropanol permits formation of 
the corresponding thioester although competing SO acyl 
transfer compromises the yield of the reaction (Figure 3a).  
However, this side reaction is not problematic when rapid 
cyclisation follows thioester formation and offers some 
practical advantages over using MESNa when scaling up 
reactions.  The high quantities of MESNa employed can only 
be removed from peptide samples by HPLC, whereas 3-
mercaptopropanol can be readily extracted into EtOAc allowing 
dilute reaction mixtures to be concentrated several hundred-fold 
prior to purification (Figure 3b).    
 
a) 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
Figure 3.  a) 3-mercaptopropanol-mediated thioester formation in model peptide H-
NPMGYTKEGC-OH as monitored by 13C NMR spectroscopy. b)  Cyclisation of sequence 
H-CFPDGRCTKSIPPHC-OH54 after 48 h before (upper trace) and after (lower trace) 
extraction with EtOAc.  
   
Thioester formation across alternative Xaa-Cys-OH motifs  
The enhanced reactivity of Xaa-Cys-OH motifs and potential 
for “thioester rescue” through cyclisation prompted a 
reinvestigation of a representative sample of Xaa-Cys-OH 
motifs towards thioester formation and cyclisation.  We were 
keen to establish whether motifs we had previously considered 
to react unacceptably slowly showed enhanced reactivity when 
prepared as C-terminal carboxylates and, if not, whether 
cyclisation could serve as a means to utilise slowly converting 
Xaa-Cys-OH motifs without fear of hydrolysis.    
 
To test this hypothesis analogues of a short peptide derived 
from antimicrobial Agardhipeptin A (cyclo-[GWPWGLH]) 
were prepared with and without an N-terminal cysteine residue.  
This allowed us to examine thioester formation and cyclisation  
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Figure 4: Thioester formation and cyclisation in Agardhipeptin A analogues (cyclo-[HGWPWXC]) 8a-f and 9a-f respectively. a)  Formation of thioesters 10a-f and (b) Cyclisation 
products 12a-f were determined by analytical HPLC.   
independently.  Consequently six pairs of peptides terminating 
in Gly-Cys, Leu-Cys, Phe-Cys, Arg-Cys, Ser-Cys, and Val-Cys 
were prepared as C-terminal carboxylates and subjected to 
NS acyl shift at 60 oC (Figure 4).  As expected peptides 
terminating in Gly-Cys (8a/9a) reacted fastest with linear 
peptide thioester (10a) and cyclic peptide (12a) initially 
forming at near identical rates.  This confirmed that, in short 
peptides, thioester formation was rate-determining with NCL 
mediated cyclisation occurring almost instantaneously and 
supports previous 13C labelling studies.58  Furthermore, the 
conversion to cyclic peptide appears slightly more efficient than 
thioester formation from the Gly-Cys-OH terminated precursor, 
presumably because the cyclic product is stable, whereas Gly-
thioesters are more susceptible to hydrolysis as the reaction 
progresses.  Unsurprisingly the Val-Cys-OH terminated 
peptides (8f/9f) were least reactive, yet still afforded significant 
thioester and cyclic peptide products when prepared as the C-
terminal carboxylate.   
 
The most surprising outcome was that most Xaa-Cys-OH 
motifs tested initially formed thioester products and cyclic 
peptides at a rate to rival the Gly-Cys-OH terminated precursor.  
Analytical HPLC analysis of the reaction mixture generally 
showed clean conversion from starting material to product in 
cyclisation reactions, suggesting that potential side reactions 
such as hydrolysis were not occurring to a significant extent 
(see supporting information for HPLC traces).  Notably, in 
most cases, small quantities of unreacted starting material (or 
starting material and thioester in the case of cyclisation 
reactions) could be observed after 48 h.  Where most Xaa-Cys-
OH motifs reacted with similar initial rates, deviations emerged 
as a consequence of side reactions occurring, mainly thioester 
hydrolysis.  Evidence of “thioester rescue” by cyclisation was 
particularly apparent in Ser-Cys and Arg-Cys and Gly-Cys 
terminated precursors where significant reduction in hydrolysis 
was clearly observed in the cyclisation reactions, supporting the 
hypothesis that cyclised product is “protected” relative to the 
free thioester.   
 
Assembly of wild-type Sunflower Trypsin Inhibitor (SFTI-1)  
Encouraged by the observation that the Arg-Cys-OH terminated 
Agardhipeptin A analogue underwent efficient cyclisation, we 
turned our attention to sunflower trypsin inhibitor-1 (SFTI-1).  
SFTI-1 is a 14-amino acid cyclic peptide with strong 
pharmaceutical potential due to its broad-spectrum protease 
inhibitory activity.59  We recently demonstrated inhibition by 
SFTI-1 analogues of human kallikrein-5 (hKLK-5) protease, a 
viable target for treatment of skin conditions/atopic 
dermatitis.54 Notably, SFTI-1 contains Arg2-Cys3 and Ile10- 
Cys11 junctions, which we had previously considered to be 
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Figure 5. a) Structural reorganisation at the Asp-Gly junction yields an aspartimide-containing side-product. b) Aspartimide formation is significantly reduced at lower (50 oC) 
reaction temperature and abolished in an SFTI(D14E) mutant (at 60 oC). c) A section of the 1H NMR spectrum of WT SFTI-1, annotated with assignments. d) A comparison of the 
observed Hα chemical shifts for our wild-type SFTI-1 (blue) with those previously published (red)63.    
 
poorly compatible with cyclisation via NS acyl shift relative 
to Cys/His/Gly-Cys-OH. Consequently when creating putative 
SFTI-1 inhibitors of hKLK-5 we were compelled to introduce 
I10G and I10H substitutions in order to aid peptide cyclisation.  
However the apparent amenability of Arg-Cys to NS acyl 
shift should enable production of wild-type SFTI-1.  
Consequently we sought to produce wild-type SFTI-1 via 
synthesis, cyclisation and oxidation of a H-
CTKSIPPICFPDGRC-OH precursor peptide. Due to the 
reduced reactivity of an Arg-Cys carboxylate compared with 
Gly-Cys (Figure 4), we first attempted cyclisation at 60 oC, and 
monitored the reaction over 48 hours using LC-MS and HPLC. 
This reaction yielded the expected product, however a side-
product less 18 Da in mass accumulated in majority (61% of 
cyclised material).  This modification was consistent with the 
conversion of aspartic acid to aspartimide (Figure 5a), a 
common occurrence at Asp-Gly junctions and a likely 
consequence of the reaction pH and elevated temperature.60-62  
From continued monitoring the reaction it was clear that 
cyclisation does not protect the peptide from aspartimide 
formation.  As the reaction time increased at 60 oC (>72 h) all 
of the material could be converted to this undesirable side-
product and aspartimide formation could be observed in the 
product as well as the linear precursor and thioester 
intermediate. 
 
We previously observed this modification, albeit to a much 
lesser extent, during cyclisation of SFTI-1 analogue (Gly/His-
Cys-OH) precursor peptides at 60oC when the reaction was 
allowed to proceed over an extended period of time (>48 h).  
However the enhanced reactivity of these motifs permitted 
efficient cyclisation at 45oC with minimal aspartimide 
formation.54  Consequently we reduced the temperature of wild-
type SFTI-1 cyclisation to 50oC, and were pleased to observe 
accumulation of the desired product in majority (62% of 
cyclised material) without significantly compromising the 
reaction rate.  Aspartimide formation as the source of the 
problem was confirmed through synthesis of the D14E mutant 
which cyclised cleanly (Figure 5b).  Although the reaction was 
successful it is noteworthy that significant quantities of linear 
precursor and thioester remained after 48 h (Figure 5b).  
Comparing the overall reaction progress with a His-Cys-OH 
terminated precursor (Figure 3b) emphasises the important 
practical consequences of seemingly small differences in 
reaction rate. 
 
Reaction products were separated using HPLC (see supporting 
information) and the unmodified peptide was oxidised in air at 
pH 8.5, yielding 1.9 mg of folded wild-type SFTI-1 from 12 mg 
of linear precursor (17% isolated yield). The structural integrity 
of the peptide was confirmed using NMR spectroscopy (Figure 
5c), revealing 1H chemical shift assignments in close agreement 
with previous studies of wild-type SFTI (Figure 5d).63   
Conclusion 
Originally we observed a preference for NS acyl transfer at 
Cys/Gly/His-Cys motifs in native peptide sequences.49 The 
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enhanced reactivity of these motifs towards thioester formation 
can be used in many instances to conduct selective acyl transfer 
reactions at the terminus of peptides containing multiple 
cysteine residues.55, 57  However this preference for 
Cys/Gly/His-Cys is not a required consensus motif.  Here we 
have shown that thioesterification is sufficiently fast at 
additional Xaa-Cys-OH motifs, particularly in shorter peptides, 
to allow efficient thioester formation and head-to tail 
cyclisation.  Furthermore, in-situ cyclisation can serve to 
“rescue” a transient thioester from hydrolysis, which can be 
significant when thioester formation is slow, or especially 
prone to hydrolysis.  Cys/Gly/His-Cys-OH motifs clearly 
undergo NS acyl transfer more rapidly with obvious practical 
advantages so pH, reaction temperature, and peptide 
concentration may all need to be optimised on a case-by case 
basis for alternative Xaa-Cys-OH motifs. Cyclisation in itself 
does not protect these peptides from aspartimide formation in 
sequences that are especially susceptible (Asp-Gly) in the 
acidic reaction medium.  However we have shown, through the 
synthesis of native SFTI-1, that this common and troublesome 
side-reaction can be significantly reduced in an Arg-Cys 
terminated thioester precursor by lowering the reaction 
temperature.  These new findings should subsequently enable 
the production of naturally occurring SFTI-1 from a bacterially 
produced linear precursor, as we have previously shown for the 
SFTI(I10G) and SFTI(I10H) analogues.54  Overall our results 
demonstrate how, even in more challenging cases, NS acyl 
transfer in native peptides can be conducted with an expanded 
repertoire of Xaa-Cys motifs.  Gaining an increased 
understanding of all of the factors that influence NS acyl 
transfer in native peptide sequences will only serve to further 
broaden its application in peptide and protein synthesis. 
Experimental Details 
All solvents and chemicals were used as received. Column 
chromatography was carried out using Merck Si 60 (40-63 μm) 
silica gel and analytical thin layer chromatography was carried 
out using Merck TLC Silica Gel 60 F254 aluminium-backed 
plates. Components were visualised using combinations of 
ultra-violet light, potassium permanganate or ninhydrin. 1H 
NMR spectra were recorded at 400, 500 or 600 MHz and 13C 
NMR spectra were recorded at 100, 125 or 150 MHz 
respectively on Bruker Avance spectrometers.  Preparative 
reversed-phase high performance liquid chromatography (RP-
HPLC) was performed using a Dionex Ultimate 3000 system 
equipped with a Phenomenex Jupiter 10µ Proteo 90A, C12, 250 
x 21.2 mm column.  Separations involved a mobile phase of 
0.1% TFA (v/v) in water (solvent A)/acetonitrile (solvent B) 
over a 5-60% acetonitrile gradient, and were monitored at 
wavelengths 230 nm, 254 nm, and 280 nm.  Analytical 
reversed-phase high performance liquid chromatography (RP-
HPLC) was performed using a Dionex Ultimate 3000 equipped 
with a Phenomenex SphereClone 5µ ODS, C18, 250 x 4.6 mm 
column.  Separations involved a mobile phase of 0.1% TFA 
(v/v) in water (solvent A)/acetonitrile (solvent B) over a 5-95% 
acetonitrile gradient, and were monitored at wavelengths 230 
nm, 254 nm, and 280 nm.  Analytical LC-MS was performed 
using a Waters Acquity UPLC SQD instrument equipped with 
an Acquity UPLC BEH, C18, 2.1 x 50 mm column. Separations 
involved a mobile phase of 0.1% formic acid (v/v) in water 
(solvent A)/acetonitrile (solvent B) over a 5-95% acetonitrile 
gradient, and were monitored at 254 nm.   
 
Automated Peptide Synthesis of Xaa-Cys-OH model peptides, 
Agardhipeptin A analogues 8/9a-f (H-[C]HGWPWXC-OH, 
where X is G, R, L, V, S or F) and SFTI-1 precursors (H-
CTKSIPPICFPDGRC-OH and H-CTKSIPPICFPEGRC-OH) 
was carried out on an Applied Biosystems ABI 433A 
automated synthesiser using standard Fmoc amino acids on a 
0.05 mmol scale, and employing pre-loaded FmocCys(Trt)-
NovaSyn®TGT resin (loading = 0.18 mmolg-1). Model peptides 
5-7 were similarly assembled starting from pre-loaded 
FmocGly-NovaSyn®TGT, FmocAsp(OtBu)-NovaSyn®TGT, 
or FmocGlu(OtBu)-NovaSyn®TGT resins.  C-terminal D-
isoform carboxylic acids were produced from NovaSyn®TGA 
(90 µm) resin (loading = 0.24 mmolg-1) and C-terminal 
carboxamides were produced from Rink Amide MBHA (100-
200 mesh) resin as previously described.  The Fast-MocTM 
protocol for SPPS was employed, using 10 equivalents of each 
Fmoc-protected amino acid.  Each coupling reaction was 
carried out using 0.45 M HBTU/HOBt in DMF, and 20% v/v 
piperidine in NMP for Fmoc deprotection.  Cleavage of the 
assembled peptide chain was carried out in TFA (95% v/v)/1,2-
ethanedithiol (2.5%)/H2O(2.5%) for 4.5 h before filtration and 
2 cycles of precipitation into cold ether followed by 
centrifugation (4000 rpm, 4°C, 15 min).  Peptides were purified 
via preparative RP-HPLC as described above, and fractions 
containing the desired peptide were identified by LC-MS and 
lyophilized to yield white powdered solids in 25-70% yields.  
 
Preparation of methyl ester terminated model peptide 4 (H-
MEELYKSG(13C-1)C-OMe).64 To Fmoc-Cys-OH (110 mg, 
0.304 mmol) in MeOH (3 mL), was added HCl (12 M, 2 drops). 
The reaction was stirred at room temperature overnight. A 
white precipitate formed that was dissolved upon addition of 
acetone (5 mL).  The solvents were removed in vacuo to afford 
the product as a white solid (80 mg, 0.224 mmol, 75%) that was 
used without further purification. Rf 0.82 (1:1 petrol:EtOAc); 
1H NMR (500 MHz, CDCl3) δ 7.77 (2H, d, J = 7.5, ArH), 7.61 
(2H, br d, J = 7.3 ArH), 7.41 (2H, t, J = 7.5, ArH), 7.32 (2H, t, J 
= 7.5, ArH), 5.79 (1H, d, J = 7.0, NH), 4.69 (1H, m, αH), 4.44 
(2H, m, FmocCH2), 4.24 (1H, t, J = 6.8, FmocCH), 3.79 (3H, s, 
OCH3), 3.06 (1H, dd, J = 14.4, 4.7, 1 × CH2SH), 3.00 (1H, J = 
14.4, 4.1, 1 × CH2SH), 1.38 (1H, t, J = 8.9, SH); 
13C NMR (125 
MHz, CDCl3) δ 170.7, 155.8, 143.9, 141.5, 127.9, 127.2, 125.3, 
120.2, 67.3, 55.4, 53.0, 47.3, 27.3; LRMS (CI) m/z 358 (14%, 
M+H+). 
 
Trityl Chloride resin, loading = 1.40 mmolg-1 (35.7 mg, 0.05 
mmol) was swelled in DMF. A solution of Fmoc-Cys-OMe (80 
mg, 0.224 mmol) in CH2Cl2 (1.5 mL) was added to the resin. 
DIPEA (156 μL, 0.896 mmol) was added and the resin shaken 
for 2 days. MeOH (25 μL) was added and the resin shaken for 5 
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min. The resin was washed with DMF and CH2Cl2 and treated 
with piperidine in DMF (20% v/v) for 15 min to remove the 
Fmoc goup.  To enable monitoring of the thioesterification 
process by 13C NMR spectroscopy Fmoc-Gly(13C-1)-OH was 
introduced,50 and the peptide was elongated by automated SPPS 
as described above. The resin was washed with DMF and 
CH2Cl2 and cleaved with Reagent K, comprising TFA (82.5% 
v/v), phenol (5% w/v), thioanisole (5% v/v), water (5% v/v), 
EDT (2.5% v/v). Reagent K (4.0 mL) was added and the resin 
stirred for 30 min. The resin was filtered off and the filtrate 
added to cold ether to induce precipitation of the peptide. The 
precipitate was collected by centrifugation (1500 rpm, 4 °C, 15 
min), the supernatant removed, and the precipitated peptide 
resuspended in ether and centrifuged once more. The white 
precipitate was dissolved in water and then purified by HPLC 
as described above.  Fractions containing the product were 
identified by LC-MS and lyophilised to afford pure peptide as a 
white solid (12 mg, 20%) 13C NMR (D2O, 125 MHz) δ 171.7; 
Calculated mass 1073.5, observed (ESI-MS) [MH]+ 1074.4 Da. 
 
General Procedure for Thioester Formation 
Peptides to be analysed by 13C NMR spectroscopy were 
dissolved to final concentrations of 1 mg mL-1 in 0.1 M sodium 
phosphate buffer (pH 5.8, prepared in D2O) containing MESNa 
(10% w/v), and TCEP.HCl (0.5% w/v). Aliquots of 0.6 mL 
were dispensed into separate 1.5 mL Eppendorf tubes and 
shaken in an Eppendorf thermomixer at 60 ºC for 48 h. The 
contents of each Eppendorf tube, once transferred to an NMR 
tube were used to obtain an independent estimation of reaction 
progress. The 13C NMR spectra were acquired at 125 MHz.  
LC-MS analysis at the end of each reaction was used to confirm 
the final distribution of peptides present. In order to determine 
thioester formation at different pH values, pH readings were 
taken with a Hanna Instruments HI 1330B electrode and pH 
210 microprocessor pH meter calibrated to pH 7 and pH 4.  For 
pH variation studies, stock reaction mixtures were neutralised 
by the addition of aqueous NaOH prior to the addition of 
buffers. 
 
SFTI-1 cyclisation and oxidation.  Backbone cyclisation was 
carried out in sodium phosphate buffer (pH 5.8, 0.1 M) 
containing peptide (1 mgmL-1), sodium 2-
mercaptoethanesulfonate (10% w/v) and tris(2-
carboxyethyl)phosphine (0.5% w/v).  The samples were heated 
at 45-60 °C in an Eppendorf thermomixer with agitation (600 
rpm) for 48 h, and monitored via analytical RP-HPLC and LC-
MS.  Backbone-cyclised SFTI-1 was purified via preparative 
RP-HPLC, as described above, yielding a white powdered solid 
in 25% isolated yield.  Finally, stirring of the cyclic peptide (0.1 
mgmL-1) in 0.1 M ammonium bicarbonate solution (pH 8.5) at 
room temperature for 24 h yielded the disulfide-bonded 
structure.  The reaction mixture was lyophilised, dissolved in 
the minimum volume of water and purified by RP-HPLC.  
Fractions containing the oxidised peptide were identified by 
LC-MS, pooled, and lyophilised to afford the target product in 
80% yield. 
 
SFTI cyclisation mediated by 3-mercapropropanol was carried 
out as above employing 10% v/v 3-mercaptopropanol in place 
of sodium 2-mercaptoethanesulfonate. After 48 h 3-
mercaptopropanol was efficiently removed from the reaction 
mixture by extraction into ethyl acetate (washed with 5 x half 
of the reaction volume).  SFTI(I10H), present in the aqueous 
phase, was then separated and purified by HPLC as described 
above. 
 
SFTI-1 NMR spectroscopy.  NMR samples were constituted in 
20 mM NaHPO4 pH 4.5 supplemented with 10% D2O. 
1H, 1H-
1H TOCSY and 1H-1H NOESY spectra were acquired at 25oC 
using a 600 MHz a Bruker Avance III spectrometer. 
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